MoneyWorks4Me

Orchid Pharma informs about company updates

31 Dec 2015 Evaluate

Orchid Pharma has informed that the company received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, Sriperumbudur, Kancheepuram District, India. The facility was inspected by USFDA in the month of May 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1851.90
Dr. Reddys Labs. 1147.55
Cipla 1359.30
Lupin 2045.05
Zydus Lifesciences 1107.90
View more..